retatrutide phase 2 results obesity nejm 2023 study sees significant weight loss in drug study Retatrutide Phase 3: 60% Achieved

Unlike earlier secretagogues, such as GHRP-2 or GHRP-6, Ipamorelin is unique because it does not trigger a rise in secondary hormones like cortisol (the stress hormone) or prolactin

PeerJ 11, e14554

Learning Activities Technology Note : The second edition of the Human Nutrition Open Educational Resource (OER) textbook features interactive learning activities

Together, they have attracted attention as a tool for interrogating the coordinated regulation of pulsatile growth hormone (GH) secretion, downstream insulin-like growth factor 1 (IGF-1) synthesis, and related metabolic pathways

They work by: Slowing gastric emptying , which prolongs feelings of fullness Reducing appetite through effects on brain centres that regulate hunger Improving insulin secretion and glucose metabolism Potentially reducing food intake and affecting eating behaviours These injections are administered subcutaneously, typically once weekly (semaglutide) or once daily (liraglutide), and have been approved by the MHRA for weight management in adults with a BMI 30 kg/m, or 27 kg/m with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity

Blood pressure, lipid profile, and HbA1c (in patients with type 2 diabetes) should be monitored as clinically indicated